A Different Method of Evaluation of the ERSPC Trial Confirms That Prostate-specific Antigen Testing Has a Significant Impact on Prostate Cancer Mortality
Year: 2014
Type: article
Source: European Urology
Institutions: Istituto per lo Studio e la Prevenzione Oncologica, Sahlgrenska University Hospital, Erasmus MC, Erasmus MC Cancer Institute, University of Tampere, Memorial Sloan Kettering Cancer Center, Klinikum Braunschweig, Kantonsspital Aarau, Provincial Institute for Hygiene, Hospital Universitario de Fuenlabrada, Centre Hospitalier Universitaire de Lille, Université Lille Nord de France
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2115817599
